Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis

Kwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, Hye Kyung Jung, Hwoon Yong Jung, Il Kwun Chung, In Kyung Sung, Jin Il Kim, Jong Hyeok Kim, Joon Seong Lee, Joong Goo Kwon, Jung Ho Park, Kyu Chan Huh, Kyung Sik Park, Moo In Park, Nayoung Kim, Oh Young Lee, Sam Ryong Jee, Sang Kil Lee, Sei Jin YounSung Kook Kim, Soo Teik Lee, Su Jin Hong, Suck Chei Choi, Tae Nyeun Kim, Young Hoon Youn, Hyo Ju Park, Min Ja Kang, Chi Hye Park, Bong Tae Kim, Sangjun Youn, Geun Seog Song, Rhee Poong-Lyul

Research output: Contribution to journal › Article › peer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science